Piśmiennictwo:
Andersen A. B.: Mycobacterium tuberculosis proteins. Structure, function, and immunological relevance. Dan. Med. Bull., 1994, 41(2), 205-215.
Belisle J. T., Braunstein M., Rosenkrands I. i wsp.: The proteome of Mycobacterium tuberculosis. (w) Tuberculosis and the tubercle bacillus. Cole S. T. (red.), ASM Press, Washington, 2005, 275-285.
Bothamley G. H., Rudd R., Festenstein F. i wsp.: Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis. Thorax, 1992, 47, 270-275.
Brightbill H. D., Libraty D. H., Krutzik S. R. i wsp.: Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science, 1999, 285, 732-735.
Camus J. C., Pryor M. J., Medigue C. i wsp.: Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology, 2002, 148, 2967-2973.
Cole S.T., Brosch R., Parkhill J. i wsp.: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998, 393, 537-544.
DeLisa M. P., Samuelson P., Palmer T. i wsp.: Genetic analysis of the twin arginine translocator secretion pathway in bacteria. J. Biol. Chem., 2002, 277 (33), 29825-29831.
Demkow U., Filewska M., Białas B. i wsp.: Antymicobacterial antibody level in pleural, pericardial and cerebrospinal fluid of patients with tuberculosis. Pneumonol. Alergol. Pol., 2004, 72 (3-4), 105-110.
Edwards K. M., Cynamon M. H., Voladri R. K. R.: Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med., 2001, 164, 2213-2219.
Gehring A. J., Rojas R. E., Canaday D. H. i wsp.: The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and FcγR1 on human macrophages through Toll-like receptor 2. Infect. Immun., 2003, 71 (8), 4487-4497.
Gomez M., Johnson S., Gennaro M. L.: Identification of secreted proteins of Mycobacterium tuberculosis by a bioinformatic approach. Infect. Immun., 2000, 68, 2323-2327.
Harboe M., Oettinger T., Wiker H. G. i wsp.: Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect. Immun., 1996, 64, 16-22.
Hutter B., Singh M.: Properties of the 40 kDa antigen of Mycobacterium tuberculosis, a functional L-alanine dehydrogenase. Biochem. J. 1999, 343, 669-672.
Kamath A. T., Feng C. G., Macdonald M. i wsp.: Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect. Immun., 1999, 67, 1702-1707.
Kashyap R. S., Dobos K. M., Belisle J.T. i wsp.: Demonstration of components of antigen 85 complex in cerebrospinal fluid of tuberculous meningitis patients. Clin. Diagn. Lab. Immunol., 2005, 12 (6), 752-758.
Kashyap R. S., Kainthla R.P., Satpute R. M. i wsp.: Demonstration of IgG antibodies to 30 Kd protein antigen in CSF for diagnosis of tuberculous meningitis by antibody-capturing ELISA. Neurol. India, 2004, 52 (3), 359-362.
Landowski C. P., Godfrey H. P., Bentley-Hibbert S. I. i wsp.: Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis. J. Clin. Microbiol., 2001, 39 (7), 2418-2424.
Lefevre P., Braibant M., De Wit L. i wsp.: Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG. J. Bacteriol. 1997, 179 (9), 2900-2906.
Lopez M., Sly L. M., Luu Y. i wsp.: The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J. Immunol., 2003, 170 (5), 2409-2416.
Lussow A. R., Barrios C., van Embden J. i wsp.: Mycobacterial heat-shock proteins as carrier molecules. Eur. J. Immunol., 1991, 21 (10), 2297-2302.
Neufert C., Pai R. K., Noss E. H. i wsp: Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. J. Immunol., 2001, 167, 1542-1549.
Pathan A. A., Wilkinson K. A., Klenerman P. i wsp.: Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 2001, 167, 5217-5225.
Preneta R., Papavinasasundaram K. G., Cozzone A. J. i wsp.: Autophosphorylation of the 16 kDa and 70 kDa antigens (Hsp 16.3 and Hsp 70) of Mycobacterium tuberculosis. Microbiology, 2004, 150, 2135-2141.
Sharma V., Arockiasamy A., Ronning D. R. i wsp.: Crystal structure of Mycobacterium tuberculosis SecA, a preprotein translocating ATPase. PNAS 2003, 100 (5), 2243-2248.
Smith I.: Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin. Microbiol. Rev., 2003, 16 (3), 463-496.
Sonnenberg M. G., Belisle J. T.: Definition of Mycobacterium tuberculosis culture filtrate proteins by two-dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect. Immun., 1997, 65, 4515-4524.
Takayama K., Wang C., Besra G. S.: Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 2005, 18 (1), 81-101.
Tian X., Cai H., Zhu Y. X.: Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64. Acta Biochim. Biophys. Sin., 2004, 36 (4), 269-276.
van Pinxteren L. A. H., Ravn P., Agger E. M. i wsp.: Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin. Diagn. Lab. Immunol., 2000, 7 (2), 155-160.
Voskuil M. I., Schnappinger D., Rutherford R. i wsp.: Regulation of the Mycobacterium tuberculosis PE/PPE genes. Tuberculosis (Edinb)., 2004, 84 (3-4), 256-262.
Young D. B.: Building a better tuberculosis vaccine. Nat. Med., 2003, 9(5), 503-504.